Mundipharma market exit

Medicine update Active

Mundipharma advised that it is leaving the Aotearoa New Zealand market.

Products we're still seeking a resolution for

Chemical name Stock available until Presentation Brand Pharmacode Update
Dihydrocodeine tartrate June 2025 Tab long-acting 60 mg DHC Continus 772887 We are in discussion with a supplier
Oxycodone hydrochloride June 2024 cap 5 mg Immediate release OxyNorm 2179741 Tender declined
Oxycodone hydrochloride June 2024 cap 10 mg immediate release OxyNorm 2179768 Tender declined
Oxycodone hydrochloride June 2024 cap 20 mg immediate release OxyNorm 2179776 Tender declined
Oxycodone hydrochloride June 2024 oral liq 5 mg per 5 ml OxyNorm 2243687 Tender declined
Morphine sulphate June 2025 Tab immediate-release 10 mg Sevredol 2520990 Tender declined
Morphine sulphate June 2025 Tab immediate-release 20 mg Sevredol 2521008 Tender declined

Oxycodone and morphine

We are talking to suppliers to ensure the continued supply of these products. We would welcome any information from suppliers about supply options. Suppliers can email ContractManagement@pharmac.govt.nz 

Items being delisted

Chemical name Presentation Brand Pharmacode Resolution
Timolol Eye drops 0.5%, gel forming Timoptol XE 204374

Restricted to no new patients 1 April 2023.

To be delisted 1 March 2024

Information for people who use Timoptol XE

Dorzolamide hydrochloride Eye drops 2% Trusopt 285226

Restricted to no new patients 1 April 2023.

To be delisted 1 March 2024

Information for people who use Trusopt

What Pharmac is doing

Pharmac is considering multiple options for products currently supplied by Mundipharma. We're reviewing each medicine to find the best solution. We will update this page with information about what is happening with each product. 

We are working closely with Mundipharma and other suppliers to ensure as little disruption as possible for people using Mundipharma's products. 

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is. 

Sign up to our email list for regular emails about supply issues and more(external link)